Bayer’s bioequivalence ruminate on comparing Adalat XL to Mylan-Nifedipine Extended Present stained, says Mylan
Mylan (Nasdaq: MYL) today reported that it has identified multiple flaws within a purported bioequivalence read sponsored past Bayer Inc. of Canada. The read compared Bayer’s antihypertensive Adalat(R) XL(R) tablets, 60 mg, marketed in Canada, to Mylan’s approved generic interpretation, Mylan-Nifedipine Extended Freedom tablets, 60 mg, marketed in Canada.
Mylan-Nifedipine Extended Put out has been sold in Canada since January 2009, after convergence Salubriousness Canada’s stringent requirements in the course of marketing support. These requirements included multiple bioequivalence studies in greatly compliance with Salubrity Canada control. These studies demonstrated bioequivalence in all cases, and put ones imprimatur on alongside Vigour Canada confirmed that Mylan’s consequence is therapeutically comparable to the kind translation. Mylan’s issue is listed as a help in all cloddish medication formularies. More than 25 million doses of Mylan-Nifedipine Extended Disenthral, 60 mg, were sold in 2009.
Mylan Failing President of Pharmacokinetics and Stimulant MetabolismRussell Rackley, Ph.D. commented: "Bayer’s observe of Mylan’s Mylan-Nifedipine Extended Report is misleading. It makes therapeutically unrelated inferences, utilizes lesser devise elements and does not clothe Form Canada Guidelines in a sprinkling areas."
Marvin C. Meyer, Ph.D., Professor Emeritus, University of Tennessee at Memphis and counselor to Mylan, has submitted a scholastic comeback to the Foreign Log of Clinical Pharmacology and Therapeutics entitled "Critical Questions In the Validity of the Bayer Deliberate over Scrutinize of ‘Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.’" Peep array and declaration is until.
Assumed the flaws in the Bayer-sponsored work, Mylan encourages healthiness suffering providers to deny its therapeutically awry conclusions and be assured that Mylan’s issue meets all of Healthiness Canada’s stringent guidelines payment bioequivalence.
Beginning: MYLAN PHARMACEUTICALS ULC
Help-Medical.net finds at this phrases:
- thu annelise nguyen
- orthoPACE
- how to steroid to the butt
- side effects of anti seizure medications
- Retractable Technologies v. OMI
- FAMCICLOVIR, teva
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
